Genprex, Inc. (GNPX)

GNPX Daily Price Range
GNPX 52-Week Price Range
Add GNPX to Watchlist
Sign Up

Genprex, Inc. (GNPX)

$1.60 USD

0.02 (1.27%)

Updated May 24 12:00am

Add GNPX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 313 in Biotech

See all “A” rated Strong Buy stocks

GNPX News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All GNPX News

Genprex, Inc. (GNPX) Company Bio

Genprex, Inc., a clinical stage gene therapy company, develops drugs to treat cancer. Its lead product candidate is Oncoprex, an active anti-cancer agent that is in Phase II clinical trials for the treatment of non-small cell lung cancer (NSCLC). It also conducts preclinical research for developing Oncoprex to be administered with immunotherapies in NSCLC; and research into other tumor suppressor genes associated with chromosome. The company was founded in 2009 and is based in Austin, Texas.

GNPX Stock Chart More Charts

GNPX Price/Volume Stats

Current price $1.60
Prev. close $1.58
Day low $1.58
Day high $1.64
50-day MA $1.77
200-day MA $1.76
52-week high $12.24
52-week low $0.95
Volume 2,000
Avg. volume 38,658
Dividend yield N/A
Market Cap 24.96M

GNPX Social Stream

Loading social stream, please wait...

View Full GNPX Social Stream

GNPX Returns

1-mo -11.11%
3-mo 7.38%
6-mo 31.15%
1-year -81.94%
3-year N/A
5-year N/A
YTD 45.45%
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
Page generated in 0.3949 seconds.